文献速递主动脉疾病

低剖面织物设计医师改良支架与标准剖面支架修复复杂腹主动脉及胸腹主动脉瘤的长期比较

Long-term comparison of physician-modified endografts with and without low-profile fabric designs for repair of complex abdominal and thoracoabdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2025-06-03

本研究回顾2007至2024年317例使用医师改良支架(PMEG)修复复杂腹主动脉瘤(CAAA)和胸腹主动脉瘤(TAAA)的患者,比较低剖面支架(LPSG,143例)与标准剖面支架(SPSG,174例)的结局。LPSG组更多用于TAAA(69% vs 48%)且每例纳入更多目标动脉(3.7±0.6 vs 3.1±1.0),但30天死亡率、主要不良事件及4年生存率、免于再干预率等两组相似。结论认为低剖面织物PMEG的围手术期和长期结局与标准剖面支架相当。

要点

  • LPSG组更多用于TAAA(69% vs 48%),每例纳入更多目标动脉(3.7±0.6 vs 3.1±1.0)。
  • LPSG组手术时间更短(257±89分钟 vs 296±107分钟),估计失血量更低(383±464 mL vs 1063±1221 mL)。
  • 30天死亡率(5% SPSG vs 4% LPSG)和主要不良事件(30例 vs 23例)两组相似。

核心结论

  • 使用低剖面织物装置的PMEG修复CAAA和TAAA的围手术期和长期结局与标准剖面支架相似,包括内漏或装置完整性问题无差异。

研究设计与样本

  • 回顾性比较研究,纳入2007至2024年317例使用PMEG修复CAAA(短颈肾下、近肾和肾周AAA)和TAAA的患者,其中SPSG组174例(55%),LPSG组143例(45%)。

主要发现

  • LPSG组更多用于TAAA(69% vs 48%),每例纳入更多目标动脉(3.7±0.6 vs 3.1±1.0)(P ≤ .001)。
  • LPSG组更多采用经皮股动脉入路(91% vs 36%),较少采用上肢入路(41% vs 75%)和髂股 conduit(6% vs 21%)(P ≤ .001)。
  • LPSG组手术时间更短(257±89分钟 vs 296±107分钟),估计失血量更低(383±464 mL vs 1063±1221 mL)(P ≤ .001)。
  • 30天死亡率(5% SPSG vs 4% LPSG)和任何主要不良事件(30例 SPSG vs 23例 LPSG)两组相似;SPSG组更可能接受早期主动脉或侧支相关再干预(13% vs 6%;P ≤ .035)。
  • 4年总生存率、免于目标动脉不稳定率、免于再干预率和免于III型内漏率两组无显著差异。

关键数值与推荐

  • 技术成功率两组相似(89% LPSG vs 93% SPSG;P ≤ .001)。

临床怎么用

  • 低剖面织物装置可用于PMEG修复CAAA和TAAA,围手术期和长期结局与标准剖面支架相当。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: After commercial approval, our institution began using the Cook Zenith Alpha low-profile stent graft (LPSG) for physician-modified endograft (PMEG) repair of complex abdominal aortic aneurysms (CAAAs) and thoracoabdominal aortic aneurysms (TAAA) owing to its smaller sheath size and wider apex-to-apex stent distances, allowing for better accommodation of modifications. We aimed to compare outcomes of PMEGs using LPSGs and the standard-profile stent graft (SPSG), Zenith TX2. METHODS: We reviewed clinical data and outcomes of patients treated using PMEGs for CAAAs (short-neck infrarenal, juxtarenal, and pararenal AAAs) and TAAAs between 2007 and 2024. End points included 30-day mortality and major adverse events, patient survival, freedom from reintervention, freedom from target artery instability, and freedom from type III endoleak. RESULTS: Of 317 patients treated with PMEGs, 228 (72%) were men with a mean age of 74 ± 9 years. SPSGs were used in 174 patients (55%) and LPSGs were used in 143 patients (45%). Patients treated with LPSGs were mostly treated for TAAAs (69% vs 48%) and subsequently had more incorporated TAs per patient (3.7 ± 0.6 vs 3.1 ± 1.0) compared with the SPSG cohort (P ≤ .001). LPSGs were used more frequently with percutaneous femoral access (91% vs 36%; P ≤ .001) and less frequently with upper extremity access (41% vs 75%; P ≤ .001) and iliofemoral conduits (6% vs 21%; P ≤ .001). Technical success rates were similar between the two groups (89% LPSG vs 93% SPSG; P ≤ .001), with shorter operating time (257 ± 89 minutes vs 296 ± 107 minutes), and lower estimated blood loss (383 ± 464 mL vs 1063 ± 1221 mL) compared with the SPSG cohort (P ≤ .001). Early (30-day) mortality (5% SPSG vs 4% LPSG) and any major adverse events (30 SPSG vs 23 LPSG) were similar between two groups; however, patients in the SPSG cohort were more likely to undergo early aortic or side-branch-related reintervention (13% vs 6%; P ≤ .035). There were no significant differences in 4-year overall survival, freedom from target artery instability, freedom from reintervention, or freedom from type III endoleak rates between the two groups. CONCLUSIONS: Repair of CAAAs and TAAAs with PMEGs using devices with low-profile fabric has similar perioperative and long-term outcomes compared with standard-profile endografts, including no difference in endoleak or issues with device integrity. Confounding factors in this comparison include learning curve, improved surveillance, and treatment of more complex aneurysms.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tabiei A, Chait J, DeMartino RR, et al. Long-term comparison of physician-modified endografts with and without low-profile fabric designs for repair of complex abdominal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2025. PMID: 40473005. doi:10.1016/j.jvs.2025.05.204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。